+919405117673

Buy Rucaparib Tablets Online from India with Worldwide Delivery

Searching for a trusted exporter of Rucaparib tablets for advanced cancer treatment? Cordium Pharmaceuticals Pvt Ltd is a leading oncology medicine exporter in India supplying high-quality Rucaparib 200mg, 250mg, and 300mg tablets to international markets with secure, fast, and affordable delivery solutions.

We specialize in supplying life-saving oncology medicines to hospitals, oncology centers, pharmacies, healthcare distributors, and personal import buyers across the globe.


About Rucaparib Tablets

Rucaparib is a targeted anti-cancer medicine used in the treatment of recurrent ovarian cancer and metastatic prostate cancer associated with BRCA gene mutations. It belongs to the PARP inhibitor class of medicines that help prevent cancer cells from repairing themselves.

Rucaparib is widely prescribed as maintenance therapy after successful chemotherapy treatment and is recognized for improving progression-free survival in eligible cancer patients.


Available Rucaparib Strengths

Cordium Pharmaceuticals Pvt Ltd exports:

  • Rucaparib 200mg Tablets
  • Rucaparib 250mg Tablets
  • Rucaparib 300mg Tablets

All medicines are sourced and supplied under strict pharmaceutical quality standards to ensure safety, efficacy, and international compliance.


Rucaparib Treatment Indications

Ovarian Cancer Treatment

Rucaparib tablets are used for:

  • Recurrent epithelial ovarian cancer
  • Fallopian tube cancer
  • Primary peritoneal cancer
  • Maintenance therapy after platinum-based chemotherapy

Prostate Cancer Treatment

Rucaparib is also indicated for:

  • Metastatic castration-resistant prostate cancer (mCRPC)
  • BRCA-positive prostate cancer patients

How Rucaparib Helps Cancer Patients

Rucaparib works by blocking PARP enzymes responsible for repairing damaged cancer cell DNA. When cancer cells fail to repair themselves, they stop growing and eventually die.

Benefits of Rucaparib Therapy

  • Advanced targeted cancer treatment
  • Oral tablet administration
  • Helps slow disease progression
  • Effective for BRCA mutation cancers
  • Supports long-term maintenance therapy
  • Recommended in selected ovarian and prostate cancers

Recommended Dosage & Administration

Rucaparib dosage depends on:

  • Cancer type
  • Patient response
  • Medical history
  • Oncologist recommendations

Available dosage strengths:

  • 200mg
  • 250mg
  • 300mg

Patients should use this medicine only under medical supervision.


Common Side Effects of Rucaparib

Some patients may experience:

  • Fatigue
  • Nausea
  • Vomiting
  • Weakness
  • Anemia
  • Diarrhea
  • Loss of appetite
  • Liver enzyme changes

Proper medical monitoring is recommended during treatment.


Why Global Buyers Choose Cordium Pharmaceuticals Pvt Ltd

Reliable Oncology Medicine Exporter from India

Cordium Pharmaceuticals Pvt Ltd Official Website has built a strong reputation for delivering oncology medicines worldwide with professional export support and competitive pricing.

Our Key Strengths

  • Trusted pharmaceutical exporter in India
  • High-quality oncology product supply
  • Affordable international pricing
  • Fast worldwide shipping
  • Secure export packaging
  • Responsive customer support
  • Bulk supply capability for hospitals & distributors
  • Reliable delivery for personal imports

International Export Countries

We export Rucaparib tablets with reliable logistics support to:

  • United States
  • Germany
  • United Kingdom
  • Netherlands
  • South Africa
  • United Arab Emirates
  • Brazil

Global Supply for Hospitals, Clinics & Pharmacies

We support:

  • Oncology Hospitals
  • Cancer Clinics
  • Retail & Wholesale Pharmacies
  • Medical Importers
  • Healthcare Distributors
  • Individual Patient Imports

Contact Cordium Pharmaceuticals Pvt Ltd for Rucaparib Orders

For bulk purchase, wholesale export inquiries, or personal import assistance, contact our team today.

Contact Information

📲 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
🌐 Website: www.cordiumpharma.com

May 12th, 2026 6:45 PM